Literature DB >> 28795258

Lipopolysaccharide aggravated DOI-induced Tourette syndrome: elaboration for recurrence of Tourette syndrome.

Long Hongyan1, Si Zhenyang2, Wang Chunyan3, Pan Qingqing3.   

Abstract

Tourette syndrome (TS) is a neurological disorder characterized by highest familial recurrence rate among neuropsychiatric diseases with complicated inheritance. Recurrence of Tourette syndrome was frequently observed in clinical. Unexpectedly, the mechanism of recurrence of Tourette syndrome was failure to elucidate. Here, we first shown that lipopolysaccharide(LPS) may played an important role in the recurrence of Tourette syndrome. The TS model in rats was induced by DOI (the selective 5-HT2A/2C agonist 1-(2, 5-dimethoxy-4-iodophenyl) -2- aminopropane). The rats were randomly divided into 4 groups:(1)Control;(2) Control + LPS; (2)TS; (3)TS + LPS. The results demonstrated that the LPS treatment significantly increased stereotypic score and autonomic activity. LPS treatment also significantly increased inflammatory cytokines such as interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in serum and striatum. Also, highly expressed TLR4, MyD88, P-NF-κBp65, P-IκBα in TS rats were increased respectively by LPS treatment as indicted in western blot analysis and immunohistochemistry analysis. Thus, it was supposed that lipopolysaccharide(LPS) may played an important role in the recurrence of Tourette syndrome and its mechanism was related to TLR/NF-κB pathway.

Entities:  

Keywords:  LPS; Recurrence; TLR/NF-κB; Tourette syndrome

Mesh:

Substances:

Year:  2017        PMID: 28795258     DOI: 10.1007/s11011-017-0084-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  21 in total

1.  The temporal dynamics of tics in Gilles de la Tourette syndrome.

Authors:  B S Peterson; J F Leckman
Journal:  Biol Psychiatry       Date:  1998-12-15       Impact factor: 13.382

2.  Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.

Authors:  Ahmad Seif Kanaan; Sarah Gerasch; Isabel García-García; Leonie Lampe; André Pampel; Alfred Anwander; Jamie Near; Harald E Möller; Kirsten Müller-Vahl
Journal:  Brain       Date:  2016-12-22       Impact factor: 13.501

3.  Picroside II Protects Rat Lung and A549 Cell Against LPS-Induced Inflammation by the NF-κB Pathway.

Authors:  Bingyu Shen; Chenxu Zhao; Chengzhen Chen; Zheng Li; Yang Li; Ye Tian; Haihua Feng
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

4.  Association of IL-1α rs17561 and IL-1 RN rs315952 polymorphisms with Tourette syndrome: a family-based study.

Authors:  Fan He; Xiaohui Shao; Mingji Yi; Yu Wang; Chuan-Yue Wang; Shiguo Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 5.  Recent advances in Tourette syndrome.

Authors:  Michael Bloch; Matthew State; Christopher Pittenger
Journal:  Curr Opin Neurol       Date:  2011-04       Impact factor: 5.710

6.  Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases.

Authors:  Astrid Morer; Wookjin Chae; Octavian Henegariu; Alfred L M Bothwell; James F Leckman; Ivana Kawikova
Journal:  Brain Behav Immun       Date:  2010-03-01       Impact factor: 7.217

7.  Dual restoring effects of gastrodin on dopamine in rat models of Tourette's syndrome.

Authors:  Feng Zhang; Anyuan Li
Journal:  Neurosci Lett       Date:  2014-12-27       Impact factor: 3.046

Review 8.  Metabolic and neuropsychiatric effects of calorie restriction and sirtuins.

Authors:  Sergiy Libert; Leonard Guarente
Journal:  Annu Rev Physiol       Date:  2012-10-01       Impact factor: 19.318

9.  (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.

Authors:  R Schreiber; M Brocco; V Audinot; A Gobert; S Veiga; M J Millan
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

Review 10.  Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease.

Authors:  Daniel M Johnstone; Cécile Moro; Jonathan Stone; Alim-Louis Benabid; John Mitrofanis
Journal:  Front Neurosci       Date:  2016-01-11       Impact factor: 4.677

View more
  1 in total

1.  Rhynchophylline Attenuates Tourette Syndrome via BDNF/NF-κB Pathway In Vivo and In Vitro.

Authors:  Hongyan Long; Jie Ruan; Mengjiao Zhang; Chunyan Wang; Yaruo Huang
Journal:  Neurotox Res       Date:  2019-06-26       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.